Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
14.31
+0.46 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
14.03
-0.28 (-1.96%)
After-hours: Mar 9, 2026, 5:58 PM EDT
Amylyx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -144.74 | -301.74 | 49.27 | -198.38 | -87.93 | |
| Depreciation & Amortization | 0.53 | 0.9 | 1.09 | 0.49 | 0.05 | |
| Loss (Gain) From Sale of Investments | -5.53 | -9.86 | -9.94 | -2.06 | 0.12 | |
| Stock-Based Compensation | 27.65 | 33.04 | 37.16 | 21.71 | 3.14 | |
| Other Operating Activities | -0.17 | 155.84 | - | - | 5.23 | |
| Change in Accounts Receivable | 0.36 | 39.6 | -24.74 | -15.31 | - | |
| Change in Inventory | - | -9.25 | -73.13 | -9.77 | - | |
| Change in Accounts Payable | 0.58 | -19.1 | 15.88 | 1.85 | 0.67 | |
| Change in Other Net Operating Assets | -2.02 | -57.08 | 16.33 | 21.58 | 3.93 | |
| Operating Cash Flow | -123.34 | -167.65 | 11.92 | -179.87 | -74.8 | |
| Capital Expenditures | -0.14 | -36.36 | -1.24 | -2.53 | -0.35 | |
| Investment in Securities | 14.18 | 112.01 | 93.29 | -236.46 | -46.05 | |
| Investing Cash Flow | 14.04 | 75.65 | 92.05 | -238.99 | -46.41 | |
| Long-Term Debt Issued | 256.31 | - | - | - | 26.16 | |
| Long-Term Debt Repaid | - | - | - | - | -0.26 | |
| Net Debt Issued (Repaid) | 256.31 | - | - | - | 25.9 | |
| Issuance of Common Stock | 4.08 | 2.13 | 6.99 | 434.64 | 0.34 | |
| Repurchase of Common Stock | -3.36 | -1.78 | -3.32 | - | - | |
| Other Financing Activities | - | - | -0.14 | -2.85 | -2.73 | |
| Financing Cash Flow | 257.03 | 0.35 | 3.54 | 431.79 | 158.51 | |
| Foreign Exchange Rate Adjustments | 1.07 | -0.44 | 0.16 | -0.07 | 0.01 | |
| Net Cash Flow | 148.8 | -92.08 | 107.68 | 12.87 | 37.31 | |
| Free Cash Flow | -123.48 | -204.01 | 10.68 | -182.4 | -75.15 | |
| Free Cash Flow Margin | - | -233.50% | 2.80% | -820.50% | -26369.12% | |
| Free Cash Flow Per Share | -1.31 | -2.99 | 0.15 | -3.12 | -11.41 | |
| Cash Income Tax Paid | - | - | 6.39 | 0.03 | - | |
| Levered Free Cash Flow | -66.99 | -134.74 | 38.36 | -105.35 | -46.85 | |
| Unlevered Free Cash Flow | -66.99 | -134.74 | 38.36 | -105.35 | -46.85 | |
| Change in Working Capital | -1.08 | -45.83 | -65.66 | -1.64 | 4.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.